Showing 421-430 of 1441 results for "".
A History of Phlebology: Warts and All, Part 3
https://practicaldermatology.com/topics/practice-management/a-history-of-phlebology-warts-and-all-part-3/20843/Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20691/Improving Your After-Tax Financial Efficiency
https://practicaldermatology.com/topics/practice-management/improving-your-after-tax-financial-efficiency/20587/Two strategies for recapturing dollars left on the table.Part 2: Is Your Financial Advisor Working for You?
https://practicaldermatology.com/topics/practice-management/part-2-is-your-financial-advisor-working-for-you/21353/Important questions to ask to find out what your advisor is doing for you.Currents
https://practicaldermatology.com/topics/psoriasis/currents-2/23005/Top 5 Skincare Trends on Social Media: What is Truly “Verified?”
https://practicaldermatology.com/issues/june-2024/top-5-skincare-trends-on-social-media-what-is-truly-verified/26556/Top 5 Skincare Trends on Social Media: What is Truly “Verified?”A Brief Compendium of Some Long-Forgotten Remedies for Dermatology
https://practicaldermatology.com/topics/general-topics/a-brief-compendium-of-some-long-forgotten-remedies-for-dermatology/20313/Is it time to drop the one-size-fits-all approach and consider remedies of the past?Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.New Products Therapeutics Focus: Acne
https://practicaldermatology.com/topics/practice-management/new-products-therapeutics-focus-acne/21134/Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.